Disclosure Of Interests In Other Entities [Text Block]

Affluent Medical - Filing #2813471

Concept	As at 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31
Disclosure of interests in other entities [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of interests in subsidiaries [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of subsidiaries [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of subsidiaries [abstract]
Disclosure of subsidiaries [line items]
Profit (loss), attributable to non-controlling interests	—	—	—	- EUR	—	—	—	—	—	—	—	—	—	—	—	—	—	- EUR
Non-controlling interests	- EUR	—	—	—	—	—	—	—	—	—	—	- EUR	—	—	—	—	—	—
Current assets	7 181 EUR	—	—	—	—	—	—	—	—	—	—	14 675 EUR	—	—	—	—	—	—
Non-current assets	52 839 EUR	—	—	—	—	—	—	—	—	—	—	55 360 EUR	—	—	—	—	—	—
Current liabilities	8 636 EUR	—	—	—	—	—	—	—	—	—	—	7 303 EUR	—	—	—	—	—	—
Non-current liabilities	17 552 EUR	—	—	—	—	—	—	—	—	—	—	19 197 EUR	—	—	—	—	—	—
Revenue	—	—	—	- EUR	—	—	—	—	—	—	—	—	—	—	—	—	—	- EUR
Profit (loss)	—	- EUR	15 227 EUR	15 227 EUR	- EUR	- EUR	- EUR	15 227 EUR	- EUR	- EUR	14 820 EUR	—	- EUR	- EUR	- EUR	- EUR	14 820 EUR	14 820 EUR
Comprehensive income	—	- EUR	15 215 EUR	15 215 EUR	- EUR	12,000 EUR	- EUR	15 227 EUR	- EUR	- EUR	14 820 EUR	—	32,000 EUR	- EUR	- EUR	1,000 EUR	14 787 EUR	14 787 EUR
Disclosure of interests in associates [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of associates [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of associates [abstract]
Disclosure of associates [line items]
Other comprehensive income	—	- EUR	12,000 EUR	12,000 EUR	- EUR	12,000 EUR	- EUR	- EUR	- EUR	- EUR	- EUR	—	32,000 EUR	- EUR	- EUR	1,000 EUR	33,000 EUR	33,000 EUR
Investments accounted for using equity method	- EUR	—	—	—	—	—	—	—	—	—	—	- EUR	—	—	—	—	—	—
Disclosure of interests in joint arrangements [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of joint ventures [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of joint ventures [abstract]
Disclosure of joint ventures [line items]
Cash and cash equivalents	2 580 EUR	—	—	—	—	—	—	—	—	—	—	11 410 EUR	—	—	—	—	—	—
Depreciation and amortisation expense	—	—	—	2 450 EUR	—	—	—	—	—	—	—	—	—	—	—	—	—	2 420 EUR
Tax expense (income)	—	—	—	173,000 EUR	—	—	—	—	—	—	—	—	—	—	—	—	—	437,000 EUR